A detailed history of Aigen Investment Management, LP transactions in Danaher Corp stock. As of the latest transaction made, Aigen Investment Management, LP holds 8,005 shares of DHR stock, worth $1.65 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
8,005
Previous 10,755 25.57%
Holding current value
$1.65 Million
Previous $2.99 Million 38.54%
% of portfolio
0.34%
Previous 0.61%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

SELL
$226.16 - $274.52 $621,940 - $754,930
-2,750 Reduced 25.57%
8,005 $1.84 Million
Q3 2024

Nov 05, 2024

BUY
$239.25 - $280.76 $2.57 Million - $3.02 Million
10,755 New
10,755 $2.99 Million
Q1 2024

May 14, 2024

BUY
$224.58 - $256.19 $491,381 - $560,543
2,188 Added 158.09%
3,572 $891,000
Q4 2023

Feb 09, 2024

BUY
$185.1 - $233.13 $256,178 - $322,651
1,384 New
1,384 $320,000
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $2.08 Million - $2.4 Million
8,666 New
8,666 $2.18 Million
Q2 2022

Aug 02, 2022

SELL
$237.11 - $299.66 $3.47 Million - $4.39 Million
-14,645 Closed
0 $0
Q1 2022

May 05, 2022

BUY
$257.27 - $315.76 $2.17 Million - $2.66 Million
8,422 Added 135.34%
14,645 $4.3 Million
Q4 2021

Feb 11, 2022

SELL
$292.08 - $329.01 $3.92 Million - $4.42 Million
-13,420 Reduced 68.32%
6,223 $1.96 Million
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $5.35 Million - $6.53 Million
19,643 New
19,643 $5.98 Million
Q2 2020

Aug 10, 2020

SELL
$128.7 - $176.83 $426,511 - $586,014
-3,314 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$121.39 - $169.05 $1.04 Million - $1.45 Million
-8,586 Reduced 72.15%
3,314 $459,000
Q4 2019

Feb 04, 2020

BUY
$133.47 - $153.48 $1.59 Million - $1.83 Million
11,900 New
11,900 $1.83 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $150B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.